ArticleFrontiers in pharmacology2024

Integration of histone modification-based risk signature with drug sensitivity analysis reveals novel therapeutic strategies for lower-grade glioma.

Jingyuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.